SIX MONTH CLINICAL OUTCOMES FOLLOWING THE IMPLANTATION OF THE BIORESORBABLE EVEROLIMUS ELUTING VASCULAR SCAFFOLD IN VESSELS SMALLER OR LARGER THAN 2.5 MM

Roberto Diletti; Yoshinobu Onuma; Vasim Farooq; Josep Gómez‐Lara; Salvatore Brugaletta; Robert‐Jan van Geuns; Evelyn Regar; Bernard De Bruyne; Dariusz Dudek; Leif Thuesen; Bernard Chevalier; Dougal McClean; Stephan Windecker; Robert Whitbourne; Li Dong; Susan Veldhof; Richard Rapoza; Krishnakutty Sudhir; Héctor M. García‐García; John A. Ormiston; Patrick W. Serruys

doi:10.1016/s0735-1097(11)61728-2

Related publications

Article2011

6-Month Clinical Outcomes Following Implantation of the Bioresorbable Everolimus-Eluting Vascular Scaffold in Vessels Smaller or Larger Than 2.5 mm

Roberto Diletti, Yoshinobu Onuma, Vasim Farooq, Josep Gómez‐Lara, Salvatore Brugaletta, Robert‐Jan van Geuns, Evelyn Regar, Bernard De Bruyne, Dariusz Dudek, Leif Thuesen, Bernard Chevalier, Dougal McClean, Stephan Windecker, Robert Whitbourn, Pieter C. Smits, Jacques Koolen, Ian T. Meredith, Dong Li, Susan Veldhof, Richard Rapoza, Héctor M. García‐García, John A. Ormiston, Patrick W. Serruys

Journal of the American College of Cardiology

Article2014

ACUTE ANGIOGRAPHIC AND SIX-MONTH CLINICAL OUTCOMES AFTER IMPLANTATION OF EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS IN LONG LESIONS (>32MM)

Yuki Ishibashi, Yoshinobu Onuma, Sjoerd T. Nauta, Roberto Diletti, Αντώνιος Καρανάσος, Takashi Muramatsu, Evelyn Regar, Nicolas M. Van Mieghem, Peter de Jaegere, Patrick W. Serruys, Felix Zijlstra, Robert van Geuns

Journal of the American College of Cardiology

Article2012

TCT-639 Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels ≤2.5 mm Diameter

Ronald Caputo, Martin B. Leon, Patrick W. Serruys, Franz‐Josef Neumann, Alan C. Yeung, Stephan Windecker, Jorge Belardi, Sigmund Silber, Ian T. Meredith, Petr Widimský, Shigeru Saito, Laura Mauri

Journal of the American College of Cardiology

Editorial Material2024

Editorial: Are inflammatory biomarkers following bioresorbable scaffold or drug-eluting stent implantation directly linked to outcomes?

Patrick W. Serruys, Kotaro Miyashita, Scot Garg, Yoshinobu Onuma

Cardiovascular revascularization medicine

Article2015

Early and late optical coherence tomography findings following everolimus-eluting bioresorbable vascular scaffold implantation in myocardial infarction: a preliminary report.

Αντώνιος Καρανάσος, Takashi Muramatsu, Roberto Diletti, Sjoerd T. Nauta, Yoshinobu Onuma, Mattie Lenzen, Tomoya Nakatani, Nicolas M. Van Mieghem, Carl Schultz, Peter de Jaegere, Patrick W. Serruys, Felix Zijlstra, E. Regar, Robert‐Jan van Geuns

PubMed

SIX MONTH CLINICAL OUTCOMES FOLLOWING THE IMPLANTATION OF THE BIORESORBABLE EVEROLIMUS ELUTING VASCULAR SCAFFOLD IN VESSELS SMALLER OR LARGER THAN 2.5 MM

Abstract

Discussion(0)

Related publications

6-Month Clinical Outcomes Following Implantation of the Bioresorbable Everolimus-Eluting Vascular Scaffold in Vessels Smaller or Larger Than 2.5 mm

ACUTE ANGIOGRAPHIC AND SIX-MONTH CLINICAL OUTCOMES AFTER IMPLANTATION OF EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS IN LONG LESIONS (>32MM)

TCT-639 Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels ≤2.5 mm Diameter

Editorial: Are inflammatory biomarkers following bioresorbable scaffold or drug-eluting stent implantation directly linked to outcomes?

Early and late optical coherence tomography findings following everolimus-eluting bioresorbable vascular scaffold implantation in myocardial infarction: a preliminary report.

SIX MONTH CLINICAL OUTCOMES FOLLOWING THE IMPLANTATION OF THE BIORESORBABLE EVEROLIMUS ELUTING VASCULAR SCAFFOLD IN VESSELS SMALLER OR LARGER THAN 2.5 MM

Abstract

Discussion(0)

Related publications

6-Month Clinical Outcomes Following Implantation of the Bioresorbable Everolimus-Eluting Vascular Scaffold in Vessels Smaller or Larger Than 2.5 mm

ACUTE ANGIOGRAPHIC AND SIX-MONTH CLINICAL OUTCOMES AFTER IMPLANTATION OF EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS IN LONG LESIONS (&gt;32MM)

TCT-639 Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels ≤2.5 mm Diameter

Editorial: Are inflammatory biomarkers following bioresorbable scaffold or drug-eluting stent implantation directly linked to outcomes?

Early and late optical coherence tomography findings following everolimus-eluting bioresorbable vascular scaffold implantation in myocardial infarction: a preliminary report.

ACUTE ANGIOGRAPHIC AND SIX-MONTH CLINICAL OUTCOMES AFTER IMPLANTATION OF EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS IN LONG LESIONS (>32MM)